Bibliography for Chapter 22. Rheumatological Guidelines
Adult-Gerontology Practice Guidelines
Second Edition 2019
- Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., . . . Hawker, G. (2010). 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism, 62(9), 2569–2581. doi:10.1002/art.27584
- American College of Rheumatology. (n.d.). ACR-endorsed criteria for rheumatic diseases. Retrieved from http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/ACR-Endorsed-Criteria
- Angeline, M. E., Gee, A. O., Shindle, M., Warren, R. F., & Rodeo, S. A. (2013). The effects of vitamin D deficiency in athletes. American Journal of Sports Medicine, 41(2), 461–464. doi:10.1177/0363546513475787
- Arthritis Foundation. (n.d.). Guidelines can help doctors choose the best osteoarthritis treatments. Retrieved from https://www.arthritis.org/about-arthritis/types/osteoarthritis/article/acr-treatment-recommendations-oa.php
- Barake, M., Arabi, A., Nakhoul, N., El-Hajj Fuleihan, G., El Ghandour, S., Klibanski, A., & Tritos, N. A. (2018). Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: A systematic review and metaanalysis. Endocrine, 59(1), 39–49. doi:10.1007/s12020-017-1440-0
- Bartels, C. (2015). Systemic lupus erythematosus (SLE). In H. S. Diamond (Ed.), Medscape. Retrieved from https://emedicine.medscape.com/article/332244-overview
- Becker, M. A. (2018). Clinical manifestations and diagnosis of gout. In P. L. Romain (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-gout
- Becker, M. A. (2018). Pharmacologic urate-lowering therapy and treatment of tophi in patients with gout. In P. L. Romain (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/prevention-of-recurrent-gout-pharmacologic-urate-lowering-therapy-and-treatment-of-tophi
- Becker, M. A. (2018). Treatment of gout flares. In P. L. Romain (Ed.), UpTo-Date. Retrieved from https://www.uptodate.com/contents/treatment-of-gout-flares
- Behnam, B., Moghimi, J., Ghorbani, R., & Ghahremanfard, F. (2013). The frequency and major determinants of depression in patients with rheumatoid arthritis. Turkish Journal of Rheumatology, 28(1), 32–37. Retrieved from http://www.journals4free.com/link.jsp?l=5851979
- Çakir, T., Evcik, F. D., Subaşi, V., Gökçe, I. Y., & Kavuncu, V. (2014). The effectiveness of aquatic exercises in the treatment of rheumatic arthritis. Turkish Journal of Osteoporosis/Turk Osteoporoz Dergisi, 20(1), 10–15. doi:10.4274/tod.08760
- Carter, S. C., Patty-Resk, C., Ruffing, V., & Hicks, D. (Eds.). (2015). Core curriculum for rheumatology nursing (1st ed.). Greenville, SC: Rheumatology Nurses Society.
- Castelino, F. (2017). Raynaud’s phenomenon. Rheumatology advisor. Retrieved from https://www.rheumatologyadvisor.com/rheumatology/raynauds-phenomenon/article/626181
- Centers for Disease Control and Prevention. (n.d.). Fibromyalgia. Retrieved from https://www.cdc.gov/arthritis/basics/fibromyalgia.htm
- Centers for Disease Control and Prevention. (n.d.). Gout. Retrieved from https://www.cdc.gov/arthritis/basics/gout.htm
- Centers for Disease Control and Prevention. (n.d.). Osteoarthritis (OA). Retrieved from https://www.cdc.gov/arthritis/basics/osteoarthritis.htm
- Centers for Disease Control and Prevention. (2015d). Systemic lupus erythematous (SLE). Retrieved from https://www.cdc.gov/lupus/facts/detailed.html
- Chang, S. F., Hong, C. M., & Yang, R. S. (2014). The performance of an online osteoporosis detection system: A sensitivity and specificity analysis. Journal of Clinical Nursing, 23(13–14), 1803–1809. doi:10.1111/jocn.12209
- Charpentier, A., Verhoeven, F., Sondag, M., Guillot, X., Prati, C., & Wendling, D. (2018). Therapeutic response to prednisone in relation to age in polymyalgia rheumatica: A comparison study. Clinical Rheumatology, 37 (3), 819–823. doi:10.1007/s10067-018-3988-3
- Chasset, F., Francès, C., Barete, S., Amoura, Z., & Arnaud, L. (2015). Influence of smoking on the efficacy of antimalarials in cutaneous lupus: A meta-analysis of the literature. Journal of the American Academy of Dermatology, 72(4), 634–639. doi:10.1016/j.jaad.2014.12.025
- Correia, L. C., Sodré, F., Garcia, G., Sabino, M., Brito, M., Kalil, F., . . . Noya-Rabelo, M. M. (2013). Relation of severe deficiency of vitamin D to cardiovascular mortality during acute coronary syndromes. American Journal of Cardiology, 111(3), 324–327. doi:10.1016/j.amjcard.2012.10.006
- Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 25(10), 2359–2381. doi:10.1007/s00198-014-2794-2
- Cummings, S., Kiel, D., & Black, D. (2018). Vitamin D supplementation and increased risk of falling: A cautionary tale of vitamin supplements retold. JAMA Internal Medicine, 176 (2), 171–172. doi:10.1001/jamainternmed.2015.7568
- Curtis, E. M., Moon, R. J., Dennison, E. M., Harvey, N. C., & Cooper, C. (2015). Recent advances in the pathogenesis and treatment of osteoporosis. Clinical Medicine (London England), 15(Suppl. 6), s92–s96. doi:10.7861/clinmedicine.15-6-s92
- Dawson-Hughes, B. (2018). Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment. In J. E. Mulder (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment
- Deveza, L. A., & Bennell, K. (2018). Patient education: Osteoarthritis treatment (beyond the basics). In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/osteoarthritis-treatment-beyond-the-basics
- Dewing, K. A. (2015). Management of patients with psoriatic arthritis. Nurse Practitioner, 40(4), 40–46. quiz 46. doi:10.1097/01.NPR.0000461950.23292.18
- Di Lorenzo, A. L. (2018). HLA-B27 syndromes. In A. A. Dahl (Ed.), Medscape. Retrieved from http://emedicine.medscape.com/article/1201027-overview#a1
- Disveld, I., Fransen, J., Rongen, G., Kienhorst, L. B. E., Zoakman, S., Janssens, H. J. E. M., . . . Janssen, M. (2018). Crystal-proven gout and characteristic gout severity factors are associated with cardiovascular disease. Journal of Rheumatology, 45(6), 858–863. doi:10.3899/jrheum.170555
- Docken, W. P., & Rosenbaum, J. T. (2017). Clinical manifestations of giant cell arteritis. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/clinical-manifestations-of-giant-cell-arteritis
- Docken, W. P. (2018). Treatment of giant cell arteritis. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/treatment-of-giant-cell-arteritis
- Farford, B., Balog, J., & Jackson, K. D. (2015). Osteoporosis: What about men? Journal of Family Practice, 64(9), 542–545, 549–552. Retrieved from https://www.mdedge.com/jfponline/article/102181/mens-health/osteoporosis-what-about-men
- Fonseca, R., Bernardes, M., Terroso, G., de Sousa, M., & Figueiredo-Braga, M. (2014). Silent burdens in disease: Fatigue and depression in SLE Autoimmune Diseases, 2014, 790724. doi:10.1155/2014/790724
- Fontenot, H. B., & Harris, A. L. (2014). Pharmacologic management of osteoporosis. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 43(2), 236–245. quiz E20. doi:10.1111/1552-6909.12285
- Fujita, T., Kutsumi, H., Sanuki, T., Hayakumo, T., & Azuma, T. (2013). Adherence to the preventive strategies for nonsteroidal anti-inflammatory drugor low-dose aspirin-induced gastrointestinal injuries. Journal of Gastroenterology, 48(5), 559–573. doi:10.1007/s00535-013-0771-8
- Gladman, D. D. (2018). Overview of the clinical manifestations of systemic lupus erythematosus in adults. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from
- https://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults
- Gota, C. E., Kaouk, S., & Wilke, W. S. (2015). Fibromyalgia and obesity: The association between body mass index and disability, depression, history of abuse, medications, and comorbidities. Journal of Clinical Rheumatology, 21(6), 289–295. doi:10.1097/RHU.0000000000000278
- Hansen-Dispenza, H. (2018). Raynaud phenomenon treatment & management. In H. S. Diamond (Ed.), Medscape. Retrieved from http://emedicine.medscape.com/article/331197-treatment
- Huffman, F., Vaccaro, J., Zarini, G., & Viera, E. (2018). Osteoporosis, activities of daily living skills, quality of life, and dietary adequacy of congregate meal participants. Geriatrics, 3(2), 24. doi:10.3390/geriatrics3020024
- Ikdahl, E., Rollefstad, S., Olsen, I. C., Kvien, T. K., Hansen, I. J., Soldal, D. M., . . . Semb, A. G. (2015). EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: An audit of the success of implementation in a rheumatology outpatient clinic. BioMed Research International, 2015, 515280. doi:10.1155/2015/515280
- Jacobson, S., Simpson, R., Lubahn, C., Hu, C., Belden, C., Davis, K. J., . . . Lorton, D. (2015). Characterization of fibromyalgia symptoms in patients 55–95 years old: A longitudinal study showing symptom persistence with suboptimal treatment. Aging Clinical and Experimental Research, 27 (1), 75–82. doi:10.1007/s40520-014-0238-7
- Jancin, B. (2017, August). How to rule out secondary causes of osteoporosis. Internal Mecidine News. Retrieved from https://www.mdedge.com/internalmedicinenews/article/144407/musculoskeletal-disorders/how-rule-out-secondary-causes
- Jordan, S., Maurer, B., Toniolo, M., Michel, B., & Distler, O. (2015). Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology, 54(8), 1454–1458. doi:10.1093/rheumatology/keu530
- Kado, D. M. (2017). Overview of hyperkyphosis in older persons. In J. Givens (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/overview-of-hyperkyphosis-in-older-persons
- Kahwati, L., Weber, R., Pan, H., Gourlay, M., LeBlanc, E., Coker-Schwimmer, M., & Viswanathan, M. (2018). Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: Evidence report and systemic review for the U.S. Preventive Services Task Force. Journal of the American Medical Association, 319(15), 1600–1612. doi:10.1001/jama.2017.21640
- Kalunian, K. C. (2014). Diagnosis and classification of osteoarthritis. UpToDate. Retrieved from http://www.uptodate.com/contents/diagnosis-and-classification-of-osteoarthritis
- Kalunian, K. C. (2015). Nonpharmacologic therapy of osteoarthritis. UpToDate. Retrieved from https://www.uptodate.com/contents/nonpharmacologic-therapy-of-osteoarthritis
- Kalunian, K. C. (2015). Treatment of osteoarthritis resistant to initial pharmacologic therapy. UpToDate. Retrieved from https://www.uptodate.com/contents/treatment-of-osteoarthritis-resistant-to-initial-pharmacologic-therapy
- Kasapoğlu, M., Altan, L., & Metin, B. (2017). The relationship between balance and vitamin 25(OH)D in fibromyalgia patients. Journal of Modern Rheumatology, 27 (5), 868–874. doi:10.1080/14397595.2016.1259603
- Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., . . . Terkeltaub, R. (2012). 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care and Research, 64(10), 1431–1446. doi:10.1002/acr.21772
- Kim, S. J., & McMahon, M. (2013). The diagnosis and treatment of systemic lupus erythematosus. Journal of Clinical Outcomes Management, 20(2), 85–95. doi:10.3238/arztebl.2015.0423
- Kinkade, S. (2007). Evaluation and treatment of acute low back pain. American Family Physician, 75(8), 1181–1188. Retrieved from https://www.aafp.org/afp/2007/0415/p1181.html
- Klippel, J. H., Stone, J. H., Crofford, L. J., & White, P. H. (Eds.). (2008). Primer on the rheumatic diseases (13th ed.). New York, NY: Springer.
- Kuganesan, T., & Huang, A. (2018). Stroke as an atypical initial presentation of giant cell arteritis. BMC Geriatrics, 18, 55. doi:10.1186/s12877-018-0738-y
- Lalani, S., Pope, J., de Leon, F., & Peschken, C. (2010). Clinical features and prognosis of late-onset systemic lupus erythematosus: Results from the 1000 Faces of Lupus study. Journal of Rheumatology, 37 (1), 38–44. doi:10.3899/jrheum.080957
- Leach, M. Z. (2017, December 10). 2017 Update: Biologics in pregnancy and breastfeeding. Retrieved from https://rheumatoidarthritis.net/living/2017-update-biologics-in-pregnancy-and-breastfeeding/
- Lee, J., Yang, J., Shin, G., Lee, G. H., Lee, W. W., Lee, E. Y., . . . Park, J. K. (2017). Elderly patients exhibit stronger inflammatory responses during gout attacks. Journal of Korean Medicine Science, 32(12), 1967–1973. doi:10.3346/jkms.2017.32.12.1967
- Liedberg, G. M., & Björk, M. (2014). Symptoms of subordinated importance in fibromyalgia when differentiating working from non-working women. Work: A Journal of Prevention, Assessment and Rehabilitation, 48(2), 155–164. doi:10.3233/WOR-131607
- Lillis, T., Tirone, V., Gandhi, N., Weinberg, S., Nika, A., Sequeira, W., . . . Jolly, M. (2018). Sleep disturbance and depression symptoms mediate the relationship between pain and cognitive dysfunction in lupus patients. Arthritis Care Research. Advance online publication. doi:10.1002/acr.23593
- Mackey, P. A., & Whitaker, M. D. (2015). Osteoporosis: A therapeutic update. Journal for Nurse Practitioners, 11(10), 1011–1017. doi:10.1016/j.nurpra.2015.08.010
- Correia, C. S. (2018). Herbal remedies, supplements & acupuncture for arthritis. Retrieved from https://www.rheumatology.org/i-am-a/patient-caregiver/treatments/herbal-remedies-supplements-acupuncture-for-arthritis
- Martin, G. M., & Roe, J. (2018). Total knee arthroplasty. In M. Ramirez Curtis & K. A. Collins (Eds.), UpToDate. Retireved from https://www.uptodate.com/contents/total-knee-arthroplasty
- Mayo, Clinic. (n.d.). Gout. Retrieved from http://www.mayoclinic.org/diseases-conditions/gout/basics/definition/con-20019400
- Miller, M. L., & Vleugels, R. A. (2016). Clinical manifestations of dermatomyositis and polymyositis in adults. In M. Ramirez Curtis & A. O. Ofori (Eds.), UpToDate. Retreived from https://www.uptodate.com/contents/clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults
- Moerman, R. V., Bootsma, H., Kroese, F. G., & Vissink, A. (2013). Sjögren’s syndrome in older patients: Aetiology, diagnosis and management. Drugs & Aging, 30(3), 137–153. doi:10.1007/s40266-013-0050-7
- Montes, R. A., Mocarzel, L. O., Lanzieri, P. G., Lopes, L. M., Carvalho, A., & Almeida, J. R. (2016). Smoking and its association with morbidity in systemic lupus erythematosus evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index: Preliminary data and systematic review. Arthritis & Rheumatology, 68(2), 441–448. doi:10.1002/art.39427
- Moreland, L. W., & Cannella, A. (2018). General principles of management of rheumatoid arthritis in adults. In P. L. Romain (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/general-principles-of-management-of-rheumatoid-arthritis-in-adults
- Nagasawa, Y., Oka, K., & Shibata, A. (2017). The effects of pain coping skills training among older outpatients with osteoarthritis. Japanese Journal of Geriatrics, 54(4), 546–554. doi:10.3143/geriatrics.54.546
- National Institute for Health and Care Excellence. (2014, February). Osteoarthritis. Care and management. Clinical guideline, No, 177 (p. 36). London, UK: Author.
- National Osteoporosis Foundation. (n.d.). Medications to prevent & treat osteoporosis. Retrieved from https://www.nof.org/?s=osteoporosis+prevention
- National Osteoporosis Foundation. (n.d.). Prevention: Vitamin D. Retrieved from https://www.nof.org/?s=osteoporosis+prevention
- Neogi, T., Jansen, T. L., Dalbeth, N., Fransen, J., Schumacher, H. R., Berendsen, D., . . . Taylor, W. J. (2015). 2015 gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases, 74(10), 1789–1798. doi:10.1136/annrheumdis-2015-208237
-
Okazaki, R. (2017). Update on recent progress in vitamin D research vitamin D insufficiency/deficiency. Clinical Calcium, 27 (11), 1601–1608. doi:CliCa171116151622 Painter, J. T., & Crofford, L. J. (2013). Chronic opioid use in fibromyalgia syndrome: A clinical review. Journal of Clinical Rheumatology, 19(2), 72–77. doi:10.1097/RHU.0b013e3182863447
Palmer, D., & El Miedany, Y. (2014). Rheumatoid arthritis: Recommendations for treat to target, 23(6), 310–315. doi:10.12968/bjon.2014.23.6.310
Pharmacist’s Letter. (2015). Potentially harmful drugs in the elderly: Beers list. Therapeutic Research Center: Prescriber’s Letter. (Supplements: PLDetailed Documents). Retrieved from https://www.PharmacistsLetter.com
Piva, S., Khoja, S., Toledo, F., Wasko, M. C., Fitzgerald, G. K., Goodpaster, B. H., . . . Delitto, A. (2018). Neuromuscular electrical stimulation compared to volitional exercise in improving muscle function in rheumatoid arthritis: A randomized pilot study. Arthritis Care and Research. Advance online publication. doi:10.1002/acr.23602
Quéméneur, T., Mouthon, L., Cacoub, P., Meyer, O., Michon-Pasturel, U., Vanhille, P., . . . Hachulla, E. (2013). Systemic vasculitis during the course of systemic sclerosis: Report of 12 cases and review of the literature. Medicine, 92(1), 1–9. doi:10.1097/MD.0b013e31827781fd
Ramos, S., Noqueira, A., Dias, A., Gonçalves, A. F., Gaio, A. R., & Duarte, R. (2015). Tuberculosis screening in patients receiving biological therapy. Acta Reumatologica Portuguesa, 40(3), 234–240. Retrieved from http://www.actareumatologica.com/archive_detail.php?id=204
Ramos-Casals, M., Brito-Zerón, P., Seror, R., Bootsma, H., Bowman, S. J., Dörner, T., . . . Vitali, C. (2015). Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology, 54(12), 2230–2238. doi:10.1093/rheumatology/kev200
Raza, K., Klareskog, L., & Holers, V. M. (2016). Predicting and preventing the development of rheumatoid arthritis. Rheumatology, 55(1), 1–3. doi:10.1093/rheumatology/kev261
Reubin, D. B., Herr, K. A., Pacala, J. T., Pollock, B. G., Potter, J. F., Semla, T. P., & Small, G. W. (2018). Geriatrics at your fingertips. (20th ed., pp. 86–96). New York, NY: American Geriatrics Society.
Rosen, H. N., & Drezner, M. K. (2018). Overview of the management of osteoporosis in postmenopausal women. In J. E. Mulder (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/overview-of-the-management-of-osteoporosis-in-postmenopausal-women
Rosen, H. N., & Walega, D. R. (2018). Osteoporotic thoracolumbar vertebral compression fractures: Clinical manifestations and treatment. In J. E. Mulder (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/osteoporotic-thoracolumbar-vertebral-compression-fractures-clinical-manifestations-and-treatment
Sadd, E. R. (2017). Polymyalgia rheumatica. In H. S. Diamond (Ed.), Medscape. Retrieved from https://emedicine.medscape.com/article/330815-overview
Sam Lim, S Rana Bayakly, A., Helmick, C. G., Gordon, C., Easley, K. A., & Drenkard, C. (2014). The incidence and prevalence of systemic lupus erythematosus, 2002–2004: The Georgia Lupus Registry. Arthritis & Rheumatology, 66 (2), 357–368. doi:10.1002/art.38239
Seetharaman, M. (2018). Giant cell arteritis (temporal arteritis) workup. In H. S. Diamond (Ed.), Medscape. Retrieved from http://emedicine.medscape.com/article/332483-workup
Sholter, D. E., & Russell, A. S. (2017). Synovial fluid analysis. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/synovial-fluid-analysis
Silpa-archa, S., Lee, J. J., & Foster, C. S. (2016). Ocular manifestations in systemic lupus erythematosus. British Journal of Ophthalmology, 100(1), 135–141. doi:10.1136/bjophthalmol-2015-306629
Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., . . . McAlindon, T. (2016). 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis & Rheumatology, 68(1), 1–26. doi:10.1002/art.39480
Smith, W. M. (2013). Gender and spondyloarthropathy-associated uveitis. Journal of Ophthalmology, 2013, 928264. doi:10.1155/2013/928264
Solomon, D. H. (2018). Overview of selective COX-2 inhibitors. In P. L. Romain (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/overview-of-selective-cox-2-inhibitors
Tillett, W., Costa, L., Jadon, D., Wallis, D., Cavill, D., McHugh, J., . . . McHugh, N . (2012) . The CllASsification for Psoriatic ARthritis (CASPAR ) criteria—a retrospecctive feasibility, sensitivity and specificity study. Journal of Rheumatology, 39, 154–156. doi:10.3899/jrheum.110845
Tunnicliffe, D. J., Singh-Grewal, D., Kim, S., Craig, J. C., & Tong, A. (2015). Diagnosis, monitoring, and treatment of systemic lupus erythematosus: A systematic review of clinical practice guidelines. Arthritis Care & Research, 67 (10), 1440–1452. doi:10.1002/acr.22591
U.S. Preventive Services Task Force 8. (2013, April). Recommendation statement: Human immunodeficiency virus (HIV) infection: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/human-immunodeficiency-virus-hiv-infection-screening?ds=1&s=HIV
U.S. Preventive Services Task Force. (2017). Draft evidence review for osteoporosis to prevent fractures: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/Page/Document/draftevidence-review/osteoporosis-screening1
U.S. Preventive Services Task Force. (2017). Draft recommendation statement: Osteoporosis to prevent fractures: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/osteoporosis-screening1
Varga, J. (2017). Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adults. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-systemic-sclerosis-scleroderma-in-adults
Varga, J., & Steen, V. (2018). Pulmonary arterial hypertension in systemic sclerosis (scleroderma): Definition, classification, risk factors, screening and prognosis. In G. Finlay (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/pulmonary-arterial-hypertension-in-systemic-sclerosis-scleroderma-definition-classification-risk-factors-screening-and-prognosis
Veronese, N., Stubbs, B., Noale, M., Solmi, M., Luchini, C., Smith, T., . . . Maggi, S. (2017). Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative. Clinical Nutrition, 36 (6), 1609–1614. doi:10.1016/j.clnu.2016.09.035
Wallace, D. J. (2017). Diagnosis and differential diagnosis of systemic lupus erythematosus in adults. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-systemic-lupus-erythematous-in-adults
Wallace, D. J. (2018). Overview of the management and prognosis of systemic lupus erythematosus in adults. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/overview-of-the-management-and-prognosis-of-systemic-lupus-erythematosus-in-adults
Wigley, F. M. (2017). Treatment of the Raynaud phenomenon resistant to initial therapy. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/treatment-of-the-raynaud-phenomenon-resistant-to-initial-therapy
Wigley, F. M. (2018). Clinical manifestations and diagnosis of Raynaud phenomenon. In M. Ramirez Curtis (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-the-raynaud-phenomenon
Wolfe, F., Clauw, D. J., Fitzcharles, M. –A., Goldenberg, D. L., Katz, R. S., Mease, P., . . . Yunus, M. B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 62(5), 600–610. doi:10.1002/acr.20140
Yurdakul, F. G., Bodur, H., Sivas, F., Başkan, B., Eser, F., & Yilmaz, O. (2015). Clinical features, treatment and monitoring in patients with polymyalgia rheumatica. Archives of Rheumatology, 30(1), 28–33. doi:10.5606/ArchRheumatol.2015.4643